MedPath

杭州仟源保灵药业有限公司

Ownership
-
Established
1994-12-30
Employees
-
Market Cap
-
Website
http://www.aoyipollen.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

22

NMPA:22

Drug Approvals

Perindopril Arginine Tablets

Product Name
精氨酸培哚普利片
Approval Number
国药准字H20249513
Approval Date
Dec 1, 2024
NMPA

Perindopril Arginine Tablets

Product Name
精氨酸培哚普利片
Approval Number
国药准字H20249514
Approval Date
Dec 1, 2024
NMPA

Alendronate Sodium Tablets

Product Name
阿仑膦酸钠片
Approval Number
国药准字H20093292
Approval Date
Feb 6, 2024
NMPA

保胎无忧片

Approval Number
国药准字Z20064033
Approval Date
Aug 6, 2023
NMPA

Folic Acid Tablets

Product Name
叶酸片
Approval Number
国药准字H20123159
Approval Date
Mar 22, 2022
NMPA

蜂皇胎胶囊

Approval Number
国药准字Z20026815
Approval Date
Mar 9, 2021
NMPA

灯盏花素片

Approval Number
国药准字Z20025047
Approval Date
Feb 19, 2021
NMPA

牛黄解毒片

Approval Number
国药准字Z33020798
Approval Date
Feb 1, 2021
NMPA

Methazolamide Tablets

Product Name
尼目克司
Approval Number
国药准字H20083760
Approval Date
Sep 27, 2020
NMPA

Ebastine Tablets

Product Name
思金
Approval Number
国药准字H20040503
Approval Date
Apr 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy